CAPTRUST Financial Advisors
BNTX icon

CAPTRUST Financial Advisors’s BioNTech BNTX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Sell
2,988
-445
-13% -$41.9K ﹤0.01% 2654
2026
Q1 		$305K Hold
3,433
– – ﹤0.01% 2373
2025
Q4 		$327K Buy
3,433
+6
+0.2% +$604 ﹤0.01% 2183
2025
Q3 		$338K Sell
3,427
-36
-1% -$3.85K ﹤0.01% 2097
2025
Q2 		$369K Buy
3,463
+26
+0.8% +$2.63K ﹤0.01% 1925
2025
Q1 		$313K Sell
3,437
-172
-5% -$19.3K ﹤0.01% 1912
2024
Q4 		$411K Sell
3,609
-69
-2% -$7.87K ﹤0.01% 1712
2024
Q3 		$437K Sell
3,678
-8,909
-71% -$819K ﹤0.01% 1649
2024
Q2 		$1.01M Sell
12,587
-500
-4% -$45.7K ﹤0.01% 1132
2024
Q1 		$1.21M Sell
13,087
-3,985
-23% -$382K ﹤0.01% 1024
2023
Q4 		$1.8M Buy
17,072
+12,907
+310% +$1.3M 0.01% 955
2023
Q3 		$453K Sell
4,165
-100
-2% -$11.1K ﹤0.01% 1706
2023
Q2 		$460K Buy
4,265
+172
+4% +$19.3K ﹤0.01% 1670
2023
Q1 		$510K Buy
4,093
+5
+0.1% +$687 ﹤0.01% 1398
2022
Q4 		$614K Buy
4,088
+94
+2% +$14.5K ﹤0.01% 1237
2022
Q3 		$539K Buy
3,994
+2,926
+274% +$447K ﹤0.01% 1208
2022
Q2 		$159K Buy
1,068
+69
+7% +$10.5K ﹤0.01% 1858
2022
Q1 		$170K Sell
999
-40
-4% -$6.72K ﹤0.01% 1837
2021
Q4 		$268K Buy
1,039
+56
+6% +$15.3K ﹤0.01% 1459
2021
Q3 		$268K Buy
983
+46
+5% +$14.6K ﹤0.01% 1361
2021
Q2 		$210K Buy
937
+10
+1% +$1.89K ﹤0.01% 1480
2021
Q1 		$101K Buy
927
+527
+132% +$56K ﹤0.01% 1941
2020
Q4 		$33K Buy
400
+325
+433% +$31.9K ﹤0.01% 2013
2020
Q3 		$5K Buy
+75
New +$5.38K ﹤0.01% 2519

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

CAPTRUST Financial Advisors's BNTX Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its BioNTech (BNTX) stake by 13% in Q2 2026, selling an estimated $41.9K and leaving 2,988 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #2654.

CAPTRUST Financial Advisors first reported a position in BNTX in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.8M in Q4 2023. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • CAPTRUST Financial Advisors held 2,988 shares of BioNTech worth $278K as of Q2 2026.
  • CAPTRUST Financial Advisors sold 445 BioNTech shares in Q2 2026, an estimated $41.9K.
  • BioNTech made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2654 holding.
  • CAPTRUST Financial Advisors first reported a position in BioNTech in Q3 2020 and has held it in 24 quarters since.
  • CAPTRUST Financial Advisors's BioNTech position peaked at $1.8M in Q4 2023.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.